Evidence map›Paper›PMID 34823367›Full record

ArticleThe Journal of urology2022

Low Serum Inhibin B/Follicle-Stimulating Hormones and Anti-Müllerian Hormone/Follicle-Stimulating Hormones Ratios as Markers of Decreased Germ Cells in Infants with Bilateral Cryptorchidism.

Taiki Kato, Kentaro Mizuno, Daisuke Matsumoto, Hidenori Nishio, Akihiro Nakane, Satoshi Kurokawa, Hideyuki Kamisawa, Tetsuji Maruyama, Shoichiro Iwatsuki, Yukihiro Umemoto and 2 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of urology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. GutFrontiers in cellular and infection microbiology · 2026
    Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Hormone Regulation in Testicular Development and Function.International journal of molecular sciences · 2024
    Review
  13. Article
  14. Review
  15. Review
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Taiki KatoDepartment of Urology, Nagoya City University East Medical Center, Nagoya, Japan.
Kentaro MizunoDepartment of Pediatric Urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.ORCID 0000-0002-9624-2009
Daisuke MatsumotoDepartment of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Hidenori NishioDepartment of Pediatric Urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Akihiro NakaneEducation and Research Center for Community Medicine, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Satoshi KurokawaDepartment of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Hideyuki KamisawaDepartment of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Tetsuji MaruyamaDepartment of Urology, Nagoya City University East Medical Center, Nagoya, Japan.
Shoichiro IwatsukiDepartment of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Yukihiro UmemotoDepartment of Urology, Nagoya City University West Medical Center, Nagoya, Japan.
Takahiro YasuiDepartment of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Yutaro HayashiDepartment of Pediatric Urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Nagoya City University · JPGTx (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeIn cryptorchidism, germ cell development failure presents from infancy and may be reflected by altered hormonal levels produced by Sertoli cells. Our object was to assess for associations between serum hormone levels and testicular histopathology in cryptorchidism with an infertility risk according to the pretreatment undescended testicular positions. MATERIALS AND

methodsPrepubertal cryptorchid boys aged 7-91 (median 20) months who underwent orchidopexy between 2014 and 2019 were included (122 unilateral [median 19 months {range 7-91}], 23 bilateral [24 months {11-81}]). We evaluated the pretreatment testicular position and size; serum hormone levels; and the mean number of germ cells per tubule transverse section (G/T). We also performed a subgroup analysis of boys aged ≤24 months at orchidopexy.

resultsSerum inhibin B levels and G/T were significantly lower in bilateral than in unilateral cryptorchid boys (median 96 [range 46-197] pg/ml vs 125 [21-354] pg/ml, p=0.026; 0.20 [0-2.59] vs 0.65 [0-4.55], p <0.001, respectively). Inhibin B/follicle-stimulating hormones (FSH) and anti-Müllerian hormone (AMH)/FSH ratios were positively correlated with G/T in bilateral cryptorchid boys aged ≤24 months (12, p=0.008 and p=0.019, respectively). Low inhibin B/FSH and AMH/FSH ratios and high FSH were predictors of impaired G/T as per receiver operating characteristic curves (p=0.019, p=0.004 and p=0.004, respectively), whereas in unilateral cryptorchid boys aged ≤24 months, serum hormone levels and G/T did not differ with the pretreatment testicular positions.

conclusionsIn bilateral cryptorchid boys aged ≤24 months at orchidopexy, low inhibin B/FSH and AMH/FSH ratios may reflect impaired G/T and future infertility risk.

Indexed as

Anti-Mullerian HormoneBiomarkersChildChild, PreschoolCryptorchidismFollicle Stimulating HormoneGerm CellsHumansInfantInhibinsMaleOrchiopexyAnti-Mullerian HormoneBiomarkersFollicle Stimulating Hormoneinhibin BInhibinscryptorchidismfollicle stimulating hormoneinfertility, maleinhibinsSertoli cells

Identifiers

PMID34823367
PMCPMC12721657
OpenAlexW3215303115

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.